Observed arrival · 2026-09-10
The Regulatory Desk
An independent brief that reads FDA enforcement records against the devices, drugs, clinic systems, and patient rules they govern.
Field notes
The homepage uses desk categories to separate warning letters, device and drug classification issues, and clinic-software changes. Entries preserve operational details rather than only naming companies: one note cites FDA letter CMS 725861, three eyelid devices, more than 177 complaints, and a repeat finding from 2019; another describes a post-clearance silence-alarms switch and device-agnostic inputs. The page also explicitly distinguishes an administrative warning letter from a court judgment.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue